Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04409262 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia (REMDACTA) |
| First Submitted : | May 28, 2020 |
| First Submitted that Met QC Criteria : | May 28, 2020 |
| First Posted : | June 1, 2020 |
| Results First Submitted : | January 28, 2022 |
| Results First Submitted that Met QC Criteria : | January 28, 2022 |
| Results First Posted : | February 14, 2022 |
| Last Update Submitted that Met QC Criteria : | January 28, 2022 |
| Last Update Posted : | February 14, 2022 |